Home
Home

pneumonia

Theravance’s Vibativ May Have Risk for Pneumonia Patients

Theravance’s Vibativ May Have Risk for Pneumonia Patients
Bloomberg

2 Important Decisions to Watch For This Week in the Biotech Sector

2 Important Decisions to Watch For This Week in the Biotech Sector
Motley Fool

Prevnar trial results needed for CDC recommendation

Prevnar trial results needed for CDC recommendation
Reuters

FDA clears Pfizer vaccine for adults over 50

FDA clears Pfizer vaccine for adults over 50
Yahoo/AP

FDA says Pfizer's best-selling Prevnar vaccine is comparable to Merck's vaccine in adults

FDA says Pfizer's best-selling Prevnar vaccine is comparable to Merck's vaccine in adults
Yahoo/AP

Pfizer's blockbuster pneumonia vaccine Prevnar 13 gets EU approval for adults 50 and older

Pfizer's blockbuster pneumonia vaccine Prevnar 13 gets EU approval for adults 50 and older
Yahoo/AP

Theravance's Vibativ Gets EU Nod

Theravance's Vibativ Gets EU Nod
Yahoo/Zacks

Pfizer’s Pneumonia Vaccine Found Effective in Ages 50 and Older

Pfizer’s Pneumonia Vaccine Found Effective in Ages 50 and Older
Bloomberg

News

Cholesterol-Lowering Drug Crestor Cuts Risk of Catching Pneumonia in Study
Bloomberg
»

News

Astellas and Theravance Announce Submission of Telavancin MAA for the Treatment of Nosocomial Pneumonia
PR-USA.net
»